Work in IPOs

We advised Clean Energy Brazil (CEB), an Isle of Man based investment vehicle offering investors the opportunity to participate in the prospective growth of the Brazilian sugar and bioethanol market, on its admission to trading on AIM with an associated share placing raising £100m for the Company, and its initial proposed joint venture investment in Brazil.

collapse

We advised Russian real estate developer MirLand Development Corporation on its admission to trading on AIM at a market capitalisation of £478m.  Merrill Lynch and Credit Suisse were joint global co-ordinators and bookrunners.  As part of the IPO, MirLand raised £143m (before expenses and before exercise of the over-allotment option).

collapse

We acted for MDY Healthcare (formerly Medisys) in connection with its delisting from the Official List, its admission to trading on AIM via the “fast track” designated markets route and its related fundraising of approximately £4.4m (net of expenses).

MDY Healthcare, which sold its operating business in April 2006 to Arkray (a transaction on which BLP also acted), is now an investing company on AIM seeking to identify investment opportunities in the medical technology, diagnostics and biopharmaceuticals sub-sectors as well as in providers of other healthcare-related products and services. It has already made its first investments.

collapse

We advised Cyberscan Technology on its £91m AIM IPO, raising a total of £34m through a share placing by Collins Stewart.  The Cyberscan group is a provider of downloadable server-based gaming systems and is the leading supplier of fixed odds betting terminals to UK bookmakers such as Ladbrokes and William Hill.  Cyberscan’s UK subsidiary and trading name is Cyberview Technology.

collapse